- HATIP #61, 19th January, 2006
- HATIP #62, 31st January, 2006
- HATIP #63, 17th February, 2006
- HATIP #64, 1st March, 2006
- HATIP #65, 16th March, 2006
- HATIP #66, 31st March, 2006
- HATIP #67, 13th April, 2006
- HATIP #68, 23rd May, 2006
- HATIP #69, 20th June, 2006
- HATIP #70, 14th July, 2006
- HATIP #71, 27th July, 2006
- HATIP #72, 3rd August, 2006
- HATIP #73, 10th August, 2006
- HATIP #74, 12th September, 2006
- HATIP #75, 21st September 2006
- HATIP #76, 20th October 2006
- HATIP #77, 1st November 2006
- HATIP #78, 28th November 2006
- HATIP #79, 19th December 2006
HATIP #79, 19th December 2006
TB transmission in healthcare settings and improving infection control
By Theo Smart
In all the news and hype about the cases of extensively drug resistant tuberculosis (XDR-TB) crisis in KwaZulu Natal, South Africa, there has been surprisingly little discussion about how and where many of the people acquired the XDR-TB infections.
“The evidence, I think, clearly points to nosocomial transmission of a very lethal organism,” said Dr Gerald Friedland of Yale University during a symposium on Infection Control at the recent 37 World Union on Lung Health Conference in Paris. Dr Friedland collaborates with the researchers in KwaZulu Natal, South Africa who reported the cases of XDR. (Nosocomial means an infection or disorder acquired in hospital).
Dr Anthony Moll was the clinician at the 350-bed district hospital in Tugela Ferry, South Africa, who first detected what would turn out to be XDR-TB in a subset of his TB patients. The hospital serves a rural district a very high prevalence of TB, with a case rate of 800 to 1,000 per 100,000 individuals and 70-80% of the cases are HIV co-infected.
Dr Moll was running a novel TB/HIV integration study offering treatment and care for both diseases in coinfected patients (with family members offering adherence support) in which the majority of patients were doing extremely well — but he noticed an unusually high and rapid mortality rate in a subset of 14 patients. Ten of these were found to have MDR- and eventually XDR-TB (6 in newly treated patients and 4 in patients who had successfully completed a course of treatment).
“The rate of MDR in newly treated cases in the study was 9%” said Dr Friedland. This was four times the rate of MDR-TB that had been reported in the last prevalence survey five years previously.
So they decided to perform a local clinical and mycobacterial survey (with drug sensitivity testing) which included three groups: 1) all the recent treatment failures and retreatment cases, 2) the in-patients in TB wards and 3) TB suspects presenting to the district hospital with TB symptoms. The survey included a total of 1539 patients, 544 of whom were culture positive, 221 (41%) of whom had MDR-TB and 53 of whom were XDR-TB.
Although MDR-TB appeared to be endemic in the area — and XDR-TB is a natural bi-product of inadequately diagnosed and treated MDR-TB — 26 (55%) of the 53 people identified with XDR-TB turned out never to have been treated for TB before.
A chart review, which included demographics, prior TB, and prior hospital admissions was performed for the people with XDR-TB, failed to reveal anything that linked all these subjects together, except that two-thirds of them had been hospitalised within the past two years — and all 53 had used the same district hospital on either an in- or outpatient basis. Also telling was the fact that contact tracing identified no additional cases in the community, and DNA fingerprinting suggested that 85% of the isolates were genetically similar.
“Looking at previous TB treatments and previous hospitalisation, putting all of that together gave us the idea that we were looking at nosocomial spread of XDR-TB,” said Dr Moll.
Transmission to people with HIV
But what’s particularly distressing is that the hospital at Tugela Ferry was the very first in the province to offer antiretroviral therapy, and thus it has served as a magnet to people with HIV in the area. 44 of the 53 were documented as HIV-positive and would have been receiving their HIV care from the hospital.
“This whole issue obviously raises the problem of tuberculosis transmission in congregate settings in hospitals,” said Dr Kevin de Cock, Director of the WHO Department of HIV/AIDS, in another session of the conference. “We are congregating patients for ARV services in hospitals where infection control has been neglected over the years.”
“Transmission of MDR and XDR-TB really must be addressed to further improve survival for HIV co-infected patients,” said Dr Friedland. “I would say quite ominously that in high-prevalence areas, the success of both antiretroviral therapy and TB-DOTS programmes is really threatened by the presence of MDR and XDR TB.”
Indeed if people perceive that waiting rooms and in-patient facilities are dangerous places (and in many situations, they clearly are), it could significantly impact on health-seeking behaviour.
These findings also call into question the reliance by many programmes upon the HIV-infected community as outreach workers, adherence counsellors and health workers in settings where they could be exposed to TB. For example, at this year’s PEPFAR Implementer’s meeting, there was a report that described a programme in India, which is using people with HIV to locate other people from their own communities — which can be particularly useful in settings where the HIV epidemic is not generalised.
But from whence did the programme operate?
The local TB clinic.
Transmission of drug-resistant TB to healthcare workers in South Africa
TB transmission is also a serious problem for professional healthcare workers. At least two of the 52 people in the first KwaZulu Natal survey who died of XDR-TB were members of the hospital staff. According to Dr Friedland, at least four other healthcare workers from the hospital died from suspected XDR-TB.
Elsewhere in South Africa, the burden of MDR- and XDR-TB may not yet be so great, but according to a poster presentation by Dr Karen Shean of the MDR-TB clinic of Brooklyn Hospital and Dr Paul Willcox of Groote Schuur Hospital, the transmission of MDR-TB is still a very real concern to healthcare workers in the Western Cape.
Cape Town is the epicentre of the TB epidemic in South Africa, with a case rate of over 1000 per 100,000. However, the reported rate of MDR is only 1% of new cases and 4% of retreatment cases (according to the last surveillance — however, given the developments in KZN, these rates could be on rise).
But between 1989 and 2005, 32 cases of MDR-TB transmission to healthcare workers were reported in the metropolitan area. The majority of the cases originated at academic hospitals, and the rest were scattered throughout the healthcare system. Most of the infected were nurses or assistants. Seventeen successfully completed the up to two-year long course of MDR-TB treatment, eight are still on treatment while seven died of MDR-TB.
But the situation might have been worse had a greater proportion of the healthcare workers been HIV-positive (only four out of 28 who tested were). Drs Shean and Wilcox wrote that the risks “will be further exacerbated by a rapidly growing HIV epidemic with the proportion of TB patients co-infected with HIV increasing.” In addition, it is likely much worse wherever MDR-TB or XDR-TB has taken hold. Dr Shean and Willcox stressed that working with drug-resistant patients carries a greater risk, because “patients who have MDR-TB are infectious for prolonged periods, increasing the risk for nosocomial and/or occupational transmission of M. tuberculosis and protection policies need to be urgently addressed.”
Transmission of TB to healthcare workers in Nairobi, Kenya
Although MDR-TB and XDR-TB are particularly frightening, many healthcare staff in resource-limited settings are at routine risk of TB exposure. This is especially a problem for staff who are HIV-positive according to Dr Shona Dalal of the US Centers for Disease Control (CDC) who described a study investigating TB transmission at a large referral hospital in Nairobi, Kenya.
In 2004, the annual TB case rate in Kenya was 320/100,000, but in Nairobi it is much higher, 830/100,000, where over 60% of the population lives in slums. Coinfection is common — the HIV prevalence in adult TB patients is 60%.
In March 2005, there were exaggerated reports in the Kenyan press that the risk of contracting TB in the wards of a large referral hospital in Nairobi was eight times higher than in the general public. Concerned about the welfare of the hospital’s staff and its ability to retain 4,800 staff members — an especially precious resource in sub-Saharan Africa — the hospital launched an investigation into the problem in collaboration with the National Leprosy and Tuberculosis Programme and the CDC.
The hospital is a large 1,800-bed referral hospital in Nairobi — but overcrowding is common and patients often have to share beds while some sleep in mattresses on the floor. In 2004, a total of over 4,500 cases of TB were diagnosed at the hospital.
In addition to determining the burden of TB among the staff, the investigation ((a chart-review on staff TB cases and a case-controlled study) explored the risk factors for TB disease among the staff.
There were 215 TB cases among staff between 2001-2005, between 34-58 each year which is equivalent to a TB case rate of 645 to a high of 1,115 cases per 100,000 with no apparent trend from year to year. These TB rates were at least twice the national rate — though quite similar to the rate in Nairobi.
HIV might have been contributing to the high case rate of the staff, but the majority (66%) of staff TB cases did not have an HIV test result recorded in their medical charts (and only 71 of the staff had medical charts available). Of those who did have HIV results in their charts, 86% were HIV-positive.
Several risk factors, identified by multivariate logistic regression analysis, were associated with TB disease in the case-controlled study:
- Working in a high-risk location was associated with an adjusted odds ratio (AOR) of 2.1 (95% CI 1.1-4.2)
A high risk location was defined as any area in the hospital where TB patients received care including casualty/emergency room — where confirmed and suspected TB cases and other patients all shared the same crowded waiting areas which had limited ventilation — the general medical wards, and the TB clinic.
“The inpatient medical wards had confirmed TB patients segregated into two rooms, said Dr Dalal. “There were large windows in these rooms, but they were often closed, particularly at night. Sputum specimens were also sometimes collected at the bedside of inpatients.”
- The number of hours spent in the same room as patients per day, AOR 1.3 (95% CI 1.2-1.5)
- The staff member’s housing situation was also associated with TB, those living in the slums had an AOR of 4.7 (1.8-12.5), while those living in the hospital-provided low-income housing had an AOR of 2.6 (1.2-5.6).
- Being HIV-infected was the highest risk factor for TB, with an AOR of 29.1 (95% CI 5.1-167)
“HIV is the strongest known risk factor for progression to TB disease once infected,” said Dr Dalal. “For their own protection and to receive appropriate care, it is crucial for staff working in hospitals in a country with a generalized HIV epidemic and high rates of TB to know their HIV status.”
The Kenyan and South African data illustrate “the risk that health care workers of all sorts are facing and we’re having increasing difficulties retaining the health work force,” said DrAlistair Reed, HIV/TB advisor to UNAIDS. He noted that he had heard many healthcare workers express concerns about working around XDR-TB, especially.
Dr Friedland agreed this is potentially a very serious problem.
“One of the great vulnerabilities in this information is the effect that it might have on the healthcare staff, which is already quite stressed and in most circumstances there is insufficient staff to start with,” said Dr Friedland. “One of the great concerns is actually loss of staff. I think the institution of appropriate infection control procedures and HIV testing and education of the staff is very important.”
In another symposium, Dr de Cock also stressed that rapid action on infection control is crucial.
“Providing a safe working environment is going to have to be a priority,” he said, “because we cannot tolerate the impression to emerge that caring for AIDS patients or caring for TB patients is dangerous and is something that people won’t want to do. That is something that we just cannot allow to emerge.”
What can be done to strengthen infection control and prevent institutional transmission of TB?
“Many people… have been working for years for this problem and its potential solutions to be recognised,” said Dr Naomi Bock, from the Global AIDS Program at the CDC. “But very little has been promoted internationally for TB infection control.”
Nevertheless, a number of interventions have been proposed that could help strengthen infection control in resource-limited settings (see resources).
These controls are essentially divided into a three level: administrative/work practice, environmental, personal respiratory protection.
Administrative controls
Administrative controls and work practice, especially the prompt isolation and treatment of TB patients, and staff education, are the most effective ways to prevent TB transmission. WHO guidelines recommend that every facility start with written infection control plan outlining prompt recognition, separation, provision of services, investigation for TB and referral of patients with suspected or confirmed TB disease.
Dr Vaira Leimane, the director of the State Agency for TB & Lung Disease of Latvia (where MDR- and XDR-TB are also problems), Dr Dalal and Dr Friedland listed a number of specific recommendations and practices instituted to improve administrative controls and work practice at their respective facilities. These should be part of any good infection control plan
- Infection control training, education and counseling — all staff should be knowledgeable about signs and symptoms of TB
- Triage coughing patients to separate waiting areas and providing expedited service for TB suspects to decrease their wait times in these crowded settings
- Only collect sputum from individuals suspected of having TB in a designated area away from other patients and staff
- Advise TB suspects about cough hygiene/etiquette on screening and provide them with a face-mask or tissues to cover their mouths and noses
- Appoint an infection control officer to monitor this and other good infection control practice
- Rapidly diagnose and treat TB — and where MDR and XDR are a concern, perform culture and drug susceptibility testing on all tuberculosis cases from the first diagnosis, rather than waiting until they fail
- Set up an isolation ward for infectious TB cases to separate them from other inpatients. Likewise, in settings where MDR- and XDR-TB are risks, set up a separate isolation ward
- Integration and foster communication between the TB and HIV programmes
Environment controls
Environmental controls are essentially any measure that might reduce the concentration of infectious droplets in the air around the healthcare facility. They can include building, setting, facility-orientation issues (and there is some overlap with some of the administrative controls such as setting up isolation wards and where sputum collection is performed) or engineering controls including, such as ventilation (natural and mechanical), filtration, and ultraviolet germicidal irradiation (UVGI).
Industrialized countries often demand the engineering solutions that are often complex and expensive (exhaust fan systems and filtration), while people in resource-limited settings are simply told to open the window.
- Improve the air circulation
Nevertheless, studies have shown that opening the window/natural ventilation can indeed dramatically improve ventilation and air circulation in a facility, but obviously the efficacy of this approach would be dependant upon the layout of the building and the size and orientation of the windows — and the time of day or year.
“However, at night the windows are closed,” said Dr Friedland. ”It’s cold in South Africa at night much of the year, and whatever is accomplished by ventilation during the day, is probably offset by what happens at night.”
Back in the pre-antibiotic days no TB ward or sanitorium would have contemplated shutting the windows at night – ventilation and fresh air was a paramount part of the treatment regime in sanatoria, because it protected against re-infection and protected staff too.
- Outdoor waiting areas
At the referral hospital in Nairobi, they are considering setting up an inexpensive covered outdoor waiting area for patients and casualty.
- UV lights
The jury is still out about how effective this strategy would be in areas with high humidity, but some researchers at the TB meeting recommended installing ultraviolet lights, which can kill or inactivate microorganisms like M. tuberculosis if there is sufficient exposure.
New findings were presented from a study in Lima, Peru (which is very humid) that found that UV lights significantly reduced airborne transmission to guinea pigs breathing contaminated air near the ceiling of an HIV/TB ward, compared to guineas pigs exposed to the same air without UV irradiation. 15 UVI guinea pigs vs 55 non-UVI guinea pigs became TB-infected (p<0.001).
Though this approach wouldn’t be foolproof, it might be more practical and affordable than many other engineering controls or reconstruction. The CDC guidelines describe how these lights could be installed and properly maintained.
Personal infection protection
The final infection control measures involve personal respiration protection, including wearing masks and, if someone is HIV infected, avoiding high-risk locations for TB transmission.
Surgical masks do not provide sufficient protection to inhale through. Respiratory masks should be made available because they have the capacity to filter particles 1 micron in size and so can protect from inhaling infectious droplet nuclei.
However, debate about about the effectiveness of the respirator masks and how long as respirator mask can be used.
“We’ve done some work in Russia,” said Dr Paul Jensen of the CDC, “where we had folks use respirators for extended periods of time, record both the chronological time that they had the respirator and also the hours of usage of the respirator. We used both the European certified respirators and the U.S. certified respirators. What we found was two things. One is for extended periods of time, of the several hundred respirators, only one failed the certification test for filtration efficiency and it just barely failed. So from the standpoint of the filter, it’s not going to be an issue.”
“The weak point of most respirators [is] the strap. What we found was about 20-percent of the people when we refit tested them, failed the fit test. The reason they failed the fit test is because that respirator wasn’t tight enough against their face. We did find a few people that did innovative things, like they kept tying knots on the strap, a couple people used shoelaces so they could pull it up tighter. That worked great.”
“I’ve tried to wear these masks and many of you have, and if you have a big nose like me, it’s a real problem to wear for more than 20 minutes or an hour,” said Dr. Friedland.
But again, the most important personal infection control issue is learning one’s HIV status. For staff, Dr Dalal and Dr Friedland both described trying to encourage the staff to get tested for HIV — and to redeploy them if necessary.
“Interventions to increase acceptability of HIV testing in an environment that is supportive and confidential should be considered. Staff who are HIV-infected should be offered optional reassignment away from areas of high TB exposure,” said Dr Dalal.
To learn how best to encourage HIV testing among healthcare workers, Dr Dalal and colleagues held some focus groups on where they would be comfortable to be tested.
“In terms of how to improve testing for HIV, I think the idea is to get places where they can have a confidential environment that’s secure and in a location where they are comfortable to go and have it on their own. The suggestion has been self-testing,” she said. “But I think those answers have to come from the staff themselves, so having focus groups or having discussions where they are providing the input would probably be the best way to go.”
Political infection control
Dr Friedland proposed one more category of infection: political. All the press attention has made this a bit easier he said.
Dr Moll, who at one point had complained on South African television about the lack of Ministry of Health support for improving infection control, now has only good things to say today — about the local provincial Department of Health at least.
But it shouldn’t come as a surprise that this is a touchy issue. Governments don’t want to hear that their public health infrastructure needs to be rebuilt, remodeled or refurbished — and without public pressure and press attention, these things are unlikely to happen.
The task of advocating for an increased budget for infection control is made more difficult because there is a paucity of data clearly demonstrating the effectiveness of many of the infection control measures aside from administrative controls. Most of the interventions and guidelines are little more than common sense. Many of these interventions need to be validated by operational research in the field — so advocating for an increased research budget might be one place to start.
Resources
Guidelines for the prevention of tuberculosis in healthcare facilities in resource-limited settings, WHO, 1999.
http://www.who.int/docstore/gtb
Tuberculosis infection control in the era of expanding HIV care and treatment; an addendum to WHO guidelines for the prevention of TB in health care settings, WHO, CDC, 2006.
Guidelines for preventing the transmission of Mycobacteria tuberculosis in health-care settings, CDC, 2005.
References
Bock N N. New tools and guidance for TB infection control. 37th Union World Conference on Lung Health, Paris, 2006.
Dalal S et al. Risk of tuberculosis among staff at a Nairobi hospital. 37th Union World Conference on Lung Health, Paris, 2006.
Escombe A R et al. Upper room ultraviolet light and negative air ionization both prevent airborne tuberculosis transmission. 37th Union World Conference on Lung Health, Paris, PC-61951-02, 2006.
Friedland G et al. Outbreak of MDR-TB among HIV-infected patients in Durban, South Africa. 37th Union World Conference on Lung Health, Paris, 2006.
Leimane V. Administrative controls for TB infection control in Latvia. 37th Union World Conference on Lung Health, Paris, 2006.
Moll A. Integration of TB and HIV therapy for coinfected patients by strengthening TB DOTS infrastructure and utilizing community and family supports. 37th Union World Conference on Lung Health, Paris, 2006.
Shean K , Willcox P. Multidrug-resistant tuberculosis in health care workers, Cape Town, South Africa. 37th Union World Conference on Lung Health, Paris, PS-62035-04, 2006.
News headlines
Most HIV-positive patients do as well as HIV-negative counterparts following surgery
In general, HIV-positive patients do no worse than HIV-negative patients after undergoing surgery, according to a retrospective study of 332 case-matched pairs by investigators from northern California. The study, published in the December issue of the Archives of Surgery found that most excess risk of infection (primarily bacterial pneumonia) or death following surgery was associated with a CD4 cell count below 50 cells/mm3 or a viral load over 30,000 copies/mL – which increased the risk of developing post-surgery-related complications fourfold and threefold, respectively.
CD4 cell loss in gut is not restored by HIV treatment, may have long-term consequences
CD4 cells in the wall of the human gut continue to be seriously depeleted even after successful antiretroviral treatment has reduced HIV in the blood to undetectable levels, according to a study of 54 people who began treatment during early or acute HIV infection published this month in PLoS Medicine. The long-term clinical consequences of this depletion of memory CD4+ cells cannot be predicted, say the researchers, but they warn clinicians will need to be vigilant for the emergence of gastrointestinal problems caused by poor immunity in patients who appear to be doing well on antiretroviral therapy over decades of treatment.
10% of new TB cases involve drug resistance
Ten percent of new tuberculosis cases involve resistance to a first-line anti-tuberculosis drug, according to a large international study published in the December 16th edition of The Lancet. The study also revealed that 1% of new tuberculosis cases are multi-drug resistant, and that three countries – Russia, China and India – all of which have growing HIV epidemics, account for the majority of cases of multi-drug resistant tuberculosis.
Is HIV causing cardiovascular disease by its own effects on cholesterol?
Provocative findings from a US-Australian research group may force the HIV field to revise its understanding of cardiovascular disease risk in people on antiretroviral treatment. The group has found that HIV’s nef protein causes macrophages, the immune system cells implicated in the development of atherosclerosis, to accumulate more cholesterol, and to develop rapidly into cells of a type found in atherosclerotic plaques, the accumulations of fatty cells and debris which cause arteries to narrow and the walls to harden.
HIV vaccine trials: measurements may overestimate participant understanding
A study investigating “informed consent” in AIDS vaccine trials in Africa has found that participants may not understand the trial risks to the extent that standard measures would indicate.
HIV treatment may need to start above 300 CD4s in HIV/hepatitis C coinfected, study suggests
Further evidence suggesting that early HIV treatment may be warranted for people with HIV and hepatitis C coinfection has emerged from a study of T-cell responses to hepatitis C published this week in PloS Medicine by a group of researchers from the Partners AIDS Research Center at Massachusetts General Hospital. Treatment before the CD4 count falls below 300 may increase the chance of sustained control of hepatitis C infection, the findings suggest.
Siblings of HIV/HCV coinfected patients also have higher mortality risk
Genetics and environmental factors may make an important contribution to the increased risk of mortality seen in individuals coinfected with HIV and hepatitis C virus (HCV), according to a study published in the January 15th edition of the Journal of Infectious Diseases. Danish investigators looked at mortality amongst the siblings of individuals who were HIV/HCV coinfected and compared it with that seen in siblings of patients only infected with HIV and the general population. They found that the brothers and sisters of coinfected patients had a higher risk of mortality than both those of the HIV-monoinfected patients and controls. They therefore suggest that genetics and socioeconomic conditions may have an important role in the excess mortality seen in coinfected patients.
Two circumcision studies halted after circumcised men's HIV risk halved
The US National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has halted two randomised clinical trials of adult male circumcision because an interim review of trial data revealed that medically performed circumcision reduced a man’s risk of acquiring HIV through heterosexual intercourse by around 50% in each study.
Hormonal contraception does not increase HIV infection risk
A study published in the January 2nd 2007 edition of AIDS has found that there is no association between the use of hormonal contraception and the risk of HIV acquisition. The study authors believe that this finding will “provide reassurance for women in a setting of moderate and high HIV prevalence who need effective contraception.” The study did, however, have one surprising result: women who used hormonal contraception and were negative at baseline for herpes simplex virus-2 (HSV-2), an ulcerative sexually transmitted infection (STI) associated with an increased risk of HIV acquisition, had a significantly increased risk of HIV acquisition than women who are non-hormonal contraception users and also HSV-2-negative.
Gilead grants royalty-free licenses for tenofovir use in microbicides
Gilead has granted royalty-free rights to the International Partnership for Microbicides to use its antiretroviral drug tenofovir in microbicides to prevent HIV transmission, the company announced this week. A royalty-free license has also been granted to CONRAD, an agency funded by the US National Institutes of Health and USAID to carry out research in reproductive health and microbicides.
Malaria treatment compromised by suppressed immunity in HIV-positive adults
Treatment of uncompromised malaria with the standard first-line regimen of sulphadoxine-pyrimethamine is significantly more likely to be unsuccessful in HIV-positive adults with CD4 cell counts below 200 cells/mm
Severe interaction between low-dose ritonavir and a blood pressure drug observed
A severe interaction between the ritonavir component of Kaletra (lopinavir/ritonavir) and the anti-hypertensive drug, nifedipine, has been reported. An individual experienced a kindney failure, a dangerous drop in blood pressure, significantly reduced urine output, as well as fluid retention. The case is reported in the January 2nd 2007 edition of AIDS.
'Molecular condom' developed - could make a microbicide more effective
Researchers in America have developed a “molecular condom” that could be capable of rapidly releasing an anti-HIV microbicide in the vagina. They believe that this could make a microbicide 90% effective.
HIV and malaria epidemics are driving each other, need to be tackled together
Malarial attacks are fuelling HIV transmission on a large scale, and prompt treatment of malaria could signficantly reduce sexual transmission of HIV, according to a major epidemiological modelling exercise published this month by the journal Science. The study also shows that where HIV prevalence is high and malaria incidence historically low, malaria incidence can grow alarmingly due to the reduced immunity in the population.
Malaria treatment leads to CD4 rise in HIV-positive people
A malaria attack can substantially reduce the CD4 cell count of an HIV-positive person, while successful treatment of malaria can result in large CD4 cell increases, a study in Zambia has shown. The authors of the study say that malarial status needs to be determined in all patients deemed eligible for treatment where CD4 counts are being used, in order to avoid premature initiation of treatment.
HIV-positive women often receive poor gynaecological care
HIV-positive women in one of the world’s richest countries are receiving suboptimal gynaecological care, according to a study published in the December 15th edition of the Journal of Acquired Immune Deficiency Syndromes. Investigators from the Swiss HIV Cohort Study found that a significant proportion of women were not having regular gynaecological examinations and PAP smears to check for cervical abnormalities. Non-white ethnicity, poor education, injecting drug use and being under or over weight were factors associated with a lack of gynaecological care.
Many patients taking efavirez experience long-term CNS side-effects
A significant number of patients taking efavirenz (Sustiva) as a component of their antiretroviral therapy experience chronic neuropsychiatric symptoms, according to a small Australian study published in the November edition of HIV Medicine. Neuropsychiatric side-effects are commonly regarded as a short-term toxicity of efavirenz therapy, but the patients in the study had been taking the drug for at least six months, and were compared with comparable patients taking long-term HIV therapy that did not include efavirenz.
Is genetic screening for abacavir hypersensitivity risk appropriate for black Africans?
Routine testing for the HLA B*5701 gene – which is thought to be associated with an increased risk of abacavir hypersensitivity reaction (HSR) – is unhelpful in black African populations and may be inappropriately denying abacavir to them, according to a commentary by two London HIV physicians which was published in STI Online last month. In the absence of ethnic-specific data regarding the reliability and utility of B*5701 testing, the commentary suggests that clinicians should prescribe abacavir to their black African patients without testing for B*5701, whilst remaining vigilant for symptoms suggestive of abacavir HSR.
US promises ‘streamlined’ process for HIV-positive tourist visas
The White House has announced that it will ease – but not remove – 20 year-old restrictions barring short-term HIV-positive visitors from entering the United States. The announcement only affects people travelling on tourist and business visas that allow entry for up to 60 days, however, and does not fundamentally alter US immigration policy. It is also unclear whether HIV-positive tourists will still have to declare their HIV status to US officials to benefit under the new rules.
US scientific chief calls for truce in abstinence vs condoms controversy
The senior medical scientist at the US government agency at the centre of the controversy over US HIV prevention policy has called for a truce in the debate that pits condoms against abstinence as solutions to the spread of HIV.
About HATIP
A regular electronic newsletter for health care workers and community-based organisations on HIV treatment in resource-limited settings.
Its publication is supported by the UK government's Department for International Development (DfID), the Diana, Princess of Wales Memorial Fund and the Stop TB Department of the World Health Organization.
Other supporters include Positive Action GlaxoSmithKline (founding sponsor); Abbott Fund; Abbott Molecular; Cavidi; Elton John AIDS Foundation; Merck & Co., Inc.; Pfizer Ltd; F Hoffmann La Roche; Schering Plough; and Tibotec, a division of Janssen Cilag.
latest aidsmap news
- Large HIV vaccine study will not go ahead
- Swiss court rules all people with HIV can be criminally liable for transmission, even if untested
- Genital shedding of HIV in women with undetectable viral load: less of it, but still happening
- Microbicides could prevent more infections in men than in women
- Knowledge of STIs poor in rural Tanzania - associated with risky sex and infection with HIV
- HIV treatment effective for infants in resource-limited settings
- Need for vigilance: two cases of abacavir allergy despite pre-treatment screening all-clear
- One third of people with HIV have experienced sexual difficulties in the past month
- Differing causes of lung infections in HIV-positive patients: implications for diagnosis and treatment
- Roche to halt HIV drug research
